<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02867436</url>
  </required_header>
  <id_info>
    <org_study_id>16-27994A</org_study_id>
    <nct_id>NCT02867436</nct_id>
  </id_info>
  <brief_title>The Effect of Gluten-free Diet on New Onset Type 1 Diabetes (T1D)</brief_title>
  <official_title>The Effect of Gluten-free Diet on Residual Beta-cell Capacity, Immune Function and Gut Microbiome in Children With Newly Diagnosed Type 1 Diabetes (T1D)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Motol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Faculty Hospital Kralovske Vinohrady</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academy of Sciences of the Czech Republic, Institute of Microbiology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Motol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this pilot study is to test whether gluten-free diet (GFD) instituted in
      children shortly after onset of Type 1 Diabetes (T1D) can decelerate the decline in beta cell
      function as compared to age matched controls. Primary objective of the trial is the change in
      C-peptide area under the curve measured by mixed-meal tolerance test (MMTT) between group on
      GFD and standard gluten-containing diet.

      Secondary objectives are:

        -  Changes in immune parameters between gluten-free diet group and control group;

        -  Differences in fecal microbiome between children on normal diet and children on GFD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in C-peptide area under the curve measured by mixed-meal tolerance test (MMTT) between group on GFD and standard gluten-containing diet.</measure>
    <time_frame>Month 1-Month 44</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in mean HbA1c at 6 and 12 months relative to baseline at month 1.</measure>
    <time_frame>Month 1-Month 44</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in mean insulin dose at 6 and 12 months relative to baseline at month 1.</measure>
    <time_frame>Month 1-Month 44</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in immunological parameters (FoxP3 Tregs, Th1 and Th17 counts) at 6 and 12 months relative to baseline at month 1.</measure>
    <time_frame>Month 1-Month 44</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in fecal microbiome between children on normal diet and children on gluten-free diet over the first year of diabetes duration;</measure>
    <time_frame>Month 1-Month 44</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Gluten-free diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Gluten-free diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gluten-free diet</intervention_name>
    <arm_group_label>Gluten-free diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 Diabetes (T1D) diagnosed according to the American Diabetes Association
             criteria

        Exclusion Criteria:

          -  negativity of the three diabetes-related autoantibodies at T1D onset;

          -  negativity of celiac-disease high risk Human Leucocyte Antigen DQB1 (HLA-DQB1) and
             Human Leucocyte Antigen DQA1 (HLA-DQA1) genotype HLA-DQB1*03:02-DQA1*03 nor
             DQB1*02-DQA1*05 molecules;

          -  celiac disease or positive transglutaminase antibody test;

          -  body mass index over two standard deviations of the age and height standard;

          -  any concomitant disease potentially influencing immune response or gluten sensitivity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Královské Vinohrady</name>
      <address>
        <city>Prague</city>
        <zip>10000</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Vosáhlo, MD</last_name>
      <phone>+420267161111</phone>
      <email>vosahlo@fnkv.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Motol</name>
      <address>
        <city>Prague</city>
        <zip>15006</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zdenek Sumnik, MD</last_name>
      <phone>+420702000087</phone>
      <email>zdenek.sumnik@lfmotol.cuni.cz</email>
    </contact>
    <contact_backup>
      <last_name>Ondrej Cinek, MD</last_name>
      <phone>+420224432026</phone>
      <email>ondrej.cinek@lfmotol.cuni.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2016</study_first_submitted>
  <study_first_submitted_qc>August 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <last_update_submitted>August 10, 2016</last_update_submitted>
  <last_update_submitted_qc>August 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Motol</investigator_affiliation>
    <investigator_full_name>Zdeněk Šumník</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

